Cargando…
Review: Effects of anti‐CD38 monoclonal antibodies on red blood cell transfusion and interventions
BACKGROUND: Highly expressed in almost all myeloma cells, CD38 is an attractive treatment target. AIM: Anti‐CD38 monoclonal antibodies have been approved for first‐line treatment in non‐transplantable multiple myeloma (MM) patients. MATERIALS AND METHODS: However, it has been found in clinical use t...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649382/ https://www.ncbi.nlm.nih.gov/pubmed/34752645 http://dx.doi.org/10.1002/jcla.23832 |